The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Prorenin Receptor Blockade Inhibits Development of Glomerulosclerosis in Diabetic Angiotensin II Type 1a Receptor–Deficient Mice
Abstract
Blockade of the renin-angiotensin system slows the progression of diabetic nephropathy but fails to abolish the development of end-stage nephropathy of diabetes. The prorenin-to-active renin ratio significantly increases in diabetes, and prorenin binding to its receptor in diabetic animal kidney induces the nephropathy without its conventional proteolytic activation, suggesting that angiotensin II (AngII) may not be the decisive factor causing the nephropathy. For identification of an AngII-independent mechanism, diabetes was induced in wild-type mice and AngII type 1a receptor gene-deficient mice by streptozotocin treatment, and their development and progression of diabetic nephropathy were assessed. In addition, prolonged inhibition of angiotensin-converting enzyme and prolonged prorenin receptor blockade were compared for their efficacy in preventing the nephropathy that occurred in diabetic AngII type 1a receptor gene-deficient mice. Only the prorenin receptor blockade with a short peptide of prorenin practically abolished the increased mitogen-activated protein kinase (MAPK) activation and nephropathy despite unaltered increase in AngII in diabetic kidney. These results indicate that the MAPK activation signal leads to the diabetic nephropathy but not other renin-angiotensin system-activated mechanisms in the glomeruli. It is not only AngII but also intraglomerular activation of MAPK by the receptor-associated prorenin that plays a pivotal role in diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 630
Ichihara, A., Hayashi, M., Kaneshiro, Y., Suzuki, F., Nakagawa, T., Tada, Y., Koura, Y., Nishiyama, A., Okada, H., Uddin, M. N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421398 · Cited by 456
Self-citationOxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
Onozato, M. L., Tojo, A., Goto, A., Fujita, T., & Wilcox, C. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00123.x · Cited by 373
Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia
Sugaya, T., Nishimatsu, S.-I., Tanimoto, K., Takimoto, E., Yamagishi, T., Imamura, K., Goto, S., Imaizumi, K., Hisada, Y., Otsuka, A., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18719 · Cited by 366
Self-citationNiimura, F., Labosky, P. A., Kakuchi, J., Okubo, S., Yoshida, H., Oikawa, T., Ichiki, T., Naftilan, A. J., Fogo, A., & Inagami, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118366 · Cited by 337
Self-citationKalluri, R., Shield, C. F., Todd, P., Hudson, B. G., & Neilson, E. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119431 · Cited by 319
Haneda, M., Araki, S.-I., Togawa, M., Sugimoto, T., Motohide, I., & Kikkawa, R. (1997) · Diabetes · doi:10.2337/diab.46.5.847 · Cited by 248
Human Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic Activation
Suzuki, F., Hayakawa, M., Nakagawa, T., Nasir, U. M., Ebihara, A., Iwasawa, A., Ishida, Y., Nakamura, Y., & Murakami, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302579200 · Cited by 185
Self-citationLévy, B. I. (2004) · Circulation · doi:10.1161/01.cir.0000096609.73772.c5 · Cited by 176
Role of growth hormone in the development of experimental renal scarring
Nahas, A. M. E., Bassett, A. H., Cope, G. H., & Carpentier, J. E. L. (1991) · Kidney International · doi:10.1038/ki.1991.175 · Cited by 155
Failure of normal adult Leydig cell development in androgen-receptor-deficient mice
O’Shaughnessy, P. J., Johnston, H. M., Willerton, L., & Baker, P. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.17.3491 · Cited by 149
Enalapril Attenuates Oxidative Stress in Diabetic Rats
de Cavanagh, E. M. V., Inserra, F., Toblli, J. E., Stella, I., Fraga, C. G., & Ferder, L. (2001) · Hypertension · doi:10.1161/hy1101.092845 · Cited by 141
Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase
Eguchi, S., & Inagami, T. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00126-9 · Cited by 140
Self-citationMechanisms of Mitogen-Activated Protein Kinase Activation in Experimental Diabetes
Awazu, M., Ishikura, K., Hida, M., & Hoshiya, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104738 · Cited by 106
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026610.48842.cb · Cited by 103
Self-citationDunlop, M., & Muggli, E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00866.x · Cited by 81
Signaling pathways and late‐onset gene induction associated with renal mesangial cell hypertrophy
Goruppi, S., Bonventre, J. V., & Kyriakis, J. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf535 · Cited by 75
Decreased Degradative Enzymes in Mesangial Cells Cultured in High Glucose Media
Leehey, D. J., Song, R. H., Alavi, N., & Singh, A. K. (1995) · Diabetes · doi:10.2337/diab.44.8.929 · Cited by 74
Renin Is Expressed in Rat Macrophage/Monocyte Cells
Iwai, N., Inagami, T., Ohmichi, N., & Kinoshita, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.399 · Cited by 71
Self-citationThyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system
Kobori, H., Ichihara, A., Suzuki, H., Miyashita, Y., Hayashi, M., & Saruta, T. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.2.e227 · Cited by 57
Self-citationc-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells
Zhang, A., Ding, G., Huang, S., Wu, Y., Pan, X., Guan, X., Chen, R., & Yang, T. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00220.2004 · Cited by 32
Hirota, N., Ichihara, A., Koura, Y., Hayashi, M., & Saruta, T. (2002) · Hypertension · doi:10.1161/hy02t2.102807 · Cited by 11
Self-citation
Cited by
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Self-citationRenin‐angiotensin system revisited
Fyhrquist, F., & Saijonmaa, O. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01981.x · Cited by 642
The pathogenesis of diabetic nephropathy
Dronavalli, S., Duka, I., & Bakris, G. L. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0894 · Cited by 625
Toma, I., Kang, J. J., Sipos, A., Vargas, S., Bansal, E., Hanner, F., Meer, E., & Peti-Peterdi, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33293 · Cited by 322
Autophagy in diabetic nephropathy
Ding, Y., & Choi, M. E. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0437 · Cited by 306
Metadata
- Authors
- Ichihara, A., Suzuki, F., Nakagawa, T., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Nabi, A. H. M. N., Nishiyama, A., Sugaya, T., Hayashi, M., & Inagami, T.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-07
- Volume
- 17
- Issue
- 7
- Pages
- 1950-1961
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2101668704
- Cited by
- 284
- References
- 25
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.